Harbor Capital Advisors Inc. Buys 111,185 Shares of Option Care Health, Inc. (NASDAQ:OPCH)

Harbor Capital Advisors Inc. lifted its stake in shares of Option Care Health, Inc. (NASDAQ:OPCH) by 115.4% during the third quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 207,560 shares of the company’s stock after purchasing an additional 111,185 shares during the quarter. Harbor Capital Advisors Inc.’s holdings in Option Care Health were worth $6,497,000 at the end of the most recent reporting period.

Several other large investors also recently made changes to their positions in OPCH. State of Michigan Retirement System lifted its stake in Option Care Health by 2.4% during the 1st quarter. State of Michigan Retirement System now owns 43,459 shares of the company’s stock valued at $1,458,000 after acquiring an additional 1,000 shares in the last quarter. Norden Group LLC raised its position in shares of Option Care Health by 42.3% in the first quarter. Norden Group LLC now owns 15,138 shares of the company’s stock valued at $508,000 after purchasing an additional 4,501 shares during the period. Diversify Advisory Services LLC bought a new stake in Option Care Health during the 1st quarter valued at $307,000. FORA Capital LLC lifted its holdings in Option Care Health by 109.7% during the 1st quarter. FORA Capital LLC now owns 23,011 shares of the company’s stock worth $772,000 after purchasing an additional 12,037 shares in the last quarter. Finally, GSA Capital Partners LLP purchased a new stake in shares of Option Care Health in the first quarter worth about $464,000. 98.05% of the stock is currently owned by institutional investors and hedge funds.

Option Care Health Stock Performance

Shares of NASDAQ OPCH opened at $24.11 on Friday. The stock’s 50-day moving average is $30.49 and its 200 day moving average is $29.91. The stock has a market cap of $4.10 billion, a price-to-earnings ratio of 20.26, a P/E/G ratio of 1.74 and a beta of 1.32. Option Care Health, Inc. has a 1-year low of $22.84 and a 1-year high of $34.63. The company has a current ratio of 1.73, a quick ratio of 1.36 and a debt-to-equity ratio of 0.77.

Option Care Health (NASDAQ:OPCH) last posted its quarterly earnings results on Wednesday, October 30th. The company reported $0.36 EPS for the quarter, topping the consensus estimate of $0.31 by $0.05. The firm had revenue of $1.28 billion for the quarter, compared to the consensus estimate of $1.22 billion. Option Care Health had a net margin of 4.37% and a return on equity of 15.30%. On average, sell-side analysts anticipate that Option Care Health, Inc. will post 1.23 EPS for the current fiscal year.

Analyst Upgrades and Downgrades

OPCH has been the topic of several recent analyst reports. JMP Securities increased their target price on shares of Option Care Health from $36.00 to $37.00 and gave the stock a “market outperform” rating in a research note on Monday, September 30th. Truist Financial lowered their price objective on Option Care Health from $41.00 to $34.00 and set a “buy” rating on the stock in a research report on Friday. Bank of America cut Option Care Health from a “buy” rating to a “neutral” rating and reduced their target price for the stock from $43.00 to $29.00 in a research report on Wednesday. Barrington Research lowered their price target on Option Care Health from $40.00 to $32.00 and set an “outperform” rating on the stock in a report on Thursday. Finally, Jefferies Financial Group lowered Option Care Health from a “buy” rating to a “hold” rating and cut their price objective for the stock from $38.00 to $26.00 in a report on Thursday. Two investment analysts have rated the stock with a hold rating and three have assigned a buy rating to the company’s stock. According to data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and an average target price of $31.60.

Insider Buying and Selling at Option Care Health

In other news, CFO Michael H. Shapiro sold 23,217 shares of Option Care Health stock in a transaction dated Thursday, August 22nd. The stock was sold at an average price of $30.95, for a total value of $718,566.15. Following the transaction, the chief financial officer now owns 247,317 shares in the company, valued at approximately $7,654,461.15. The trade was a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. In other news, CFO Michael H. Shapiro sold 23,217 shares of the firm’s stock in a transaction that occurred on Thursday, August 22nd. The shares were sold at an average price of $30.95, for a total value of $718,566.15. Following the transaction, the chief financial officer now owns 247,317 shares in the company, valued at approximately $7,654,461.15. This trade represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, Director Elizabeth Quadros Betten sold 47,531 shares of Option Care Health stock in a transaction on Wednesday, August 21st. The stock was sold at an average price of $31.09, for a total transaction of $1,477,738.79. Following the completion of the transaction, the director now directly owns 21,339 shares in the company, valued at approximately $663,429.51. The trade was a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Company insiders own 0.64% of the company’s stock.

Option Care Health Profile

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn’s disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.